Quantcast

Latest AxoGen Inc. Stories

2014-07-15 23:05:17

Nerve repair company to announce results and host call for investors. Alachua, FL (PRWEB) July 15, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, will report results for the second quarter ended June 30, 2014 on Monday, August 4, 2014 after the close of the markets. The Company will host a conference call and webcast for the investment community on Monday, August 4, 2014 at 4:30 PM ET. Investors within the United...

2014-06-18 23:11:38

Expanded outcomes data from the Ranger® Registry to be presented Alachua, FL (PRWEB) June 18, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, today announced the acceptance of two clinical presentations on the use of Avance® Nerve Graft and a scientific presentation on the use of coaptation aids in nerve repair at the 29th Congress of the Federation of European Societies for Surgery of the Hand (FESSH), June...

2014-06-16 23:07:56

Nerve repair company achieves requirements for inclusion in equity market index Alachua, FL (PRWEB) June 16, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, announced today that it was included on a preliminary list of additions to the Russell Microcap® Index according to information posted by Russell Investments on June 13, 2014. The final 2014 reconstitution of the Russell Indexes will take...

2014-06-09 23:07:46

Nerve Repair Company AXGN to participate in investor conference in New York Alachua, FL (PRWEB) June 09, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, is scheduled to present at the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24, 2014 at 12:30pm (ET) at the Westin New York Grand Central. A live webcast and subsequent archived replay of the Company’s presentation may be accessed...

2014-06-04 23:10:04

$1.9 Million in Grant funding will explore application of novel stem cells and development of branched grafts for complex nerve repair Alachua, FL (PRWEB) June 04, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it would share in the award of two Department of Defense Grants totaling approximately $1.9 million with Brigham and Women’s Hospital in Boston (BWH). The grants, awarded to Principal...

2014-05-12 23:01:47

Gregory Freitag Transitions to General Counsel and SVP of Business Development Alachua, FL (PRWEB) May 12, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion US peripheral nerve repair market, announced the appointment of Lee Robert Johnston, Jr, as Chief Financial Officer, effective May 12, 2014. Mr. Johnston will report directly to Karen Zaderej, President and Chief Executive Officer. Gregory Freitag, who previously held the position of...

2014-05-05 23:08:17

AxoGen selected as one of 20 presenting companies Alachua, FL (PRWEB) May 05, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion U.S. peripheral nerve repair market, announced today that it has been selected from a record number of applicants as a presenting company at the 2014 Conference of the Southeastern Medical Device Association (SEMDA). The eighth annual SEMDA Conference, “Thriving During Healthcare Reform,” will be held May 7-8,...

2014-04-30 23:06:56

Quarterly Revenues Exceeds $3 Million for First Time in Company History. Gross margin expands to 77.7%. Alachua, FL (PRWEB) April 30, 2014 AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the $1.6 billion U.S. peripheral nerve repair market, announced financial results for the first quarter ended March 31, 2014. Revenue for the quarter grew 46% to $3.14 million compared to $2.14 million for the first quarter of 2013. “We are pleased to see strong results...

2014-04-28 23:08:35

Company to feature portfolio of products for peripheral nerve repair, protection and regeneration at ACOMS Annual Meeting Alachua, FL (PRWEB) April 28, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, announced today that it will be highlighting its products at the American College of Oral and Maxillofacial (ACOMS) 35th Annual Scientific Conference and Exhibition, April 27-30 in Las Vegas, Nevada. AxoGen is exhibiting its full...

2014-04-16 23:10:26

AxoGen, Inc. will report results for the first quarter ended March 31, 2014 on Wednesday, April 30, 2014 after the market closes. Alachua, Florida (PRWEB) April 16, 2014 AxoGen, Inc. (NASDAQ: AXGN), the emerging leader of the $1.6 billion U.S. peripheral nerve repair market, will report results for the first quarter ended March 31, 2014 on Wednesday, April 30, 2014 after the market closes. The Company will host a conference call and webcast for the investment community on Wednesday, April...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related